Compare iShares 7-10 Year Treasury Bond ETF (IEF) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares 7-10 Year Treasury Bond ETF vs 10X Genomics Inc — how do they compare? iShares 7-10 Year Treasury Bond ETF trades at $93.16, while 10X Genomics Inc trades at $59.34 (market cap $7.61B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, iShares 7-10 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| IEF | TXG | |
|---|---|---|
52-Week High | $97.99 | $58.57 |
52-Week Low | $92.76 | $11.34 |
Market Cap | — | $7.61B |
Sector | — | Health |
Enterprise Value | — | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares 7-10 Year Treasury Bond ETF
The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.
Read more on IEF →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
